Literature DB >> 18606198

Accuracy of a routine real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia.

Judith Fillaux1, Sonia Malvy, Muriel Alvarez, Richard Fabre, Sophie Cassaing, Bruno Marchou, Marie-Denise Linas, Antoine Berry.   

Abstract

Pneumocystis jirovecii is a common cause of life-threatening pneumonia among immunocompromised patients. Using 400 fresh bronchoalveolar lavage samples, we compared prospectively routine direct immunofluorescence assay (DFA) and a real-time PCR assay, performed on a LightCycler system, for the detection of P. jirovecii. Among the 66 PCR positive samples, 31 were positive by DFA. No patient was found as having the pattern "PCR--ve/DFA+ve". The semi-quantification of the P. jirovecii DNA was represented by the cycle threshold (Ct). Using DFA as the gold standard, the sensitivity of the PCR was 100% for Ct > or = 28 and the specificity was 100% for Ct < 22. Between these two points, the results could be discrepant. The patients of the "22 < or = Ct < 28" group presented more frequently with a radiological interstitial syndrome than the "Ct > or = 28" group, and presented less frequently with HIV-infection and elevated lactate dehydrogenase (LDH) assay than in the "Ct < 22" group. A negative PCR allowed us to exclude the P. jirovecii pneumonia. The real-time PCR assay seems to be an accurate diagnosis method and could replace the DFA. The semi-quantitative results should be helpful to distinguish colonized, subclinically infected and P. jirovecii pneumonia patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606198     DOI: 10.1016/j.mimet.2008.06.009

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  24 in total

1.  Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients.

Authors:  Françoise Botterel; Odile Cabaret; Françoise Foulet; Catherine Cordonnier; Jean-Marc Costa; Stéphane Bretagne
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  PCR diagnosis of Pneumocystis pneumonia: a bivariate meta-analysis.

Authors:  Yuan Lu; Guoya Ling; Chenyi Qiang; Qinshou Ming; Cong Wu; Ke Wang; Zouxiao Ying
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

3.  Performances of Four Real-Time PCR Assays for Diagnosis of Pneumocystis jirovecii Pneumonia.

Authors:  Milène Sasso; Elsa Chastang-Dumas; Sophie Bastide; Sandrine Alonso; Catherine Lechiche; Nathalie Bourgeois; Laurence Lachaud
Journal:  J Clin Microbiol       Date:  2015-12-30       Impact factor: 5.948

4.  Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii on the fully automated BD MAX platform.

Authors:  Alexander H Dalpke; Marjeta Hofko; Stefan Zimmermann
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

5.  Radiological presentation of Pneumocystis jiroveci pneumonia mimicking bacterial pneumonia.

Authors:  Bruno Langevin; Mohamed Saleh
Journal:  BMJ Case Rep       Date:  2016-06-03

6.  Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii.

Authors:  M Louis; J Guitard; M Jodar; T Ancelle; D Magne; O Lascols; C Hennequin
Journal:  J Clin Microbiol       Date:  2015-10-14       Impact factor: 5.948

7.  Molecular Diagnosis of Pneumocystis jirovecii Pneumonia by Use of Oral Wash Samples in Immunocompromised Patients: Usefulness and Importance of the DNA Target.

Authors:  Lidia Goterris; Miguel Angel Mancebo Fernández; Juan Aguilar-Company; Vicenç Falcó; Isabel Ruiz-Camps; M Teresa Martín-Gómez
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

Review 8.  Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.

Authors:  Marjorie Bateman; Rita Oladele; Jay K Kolls
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

9.  Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.

Authors:  Céline Damiani; Solène Le Gal; Cécilia Da Costa; Michèle Virmaux; Gilles Nevez; Anne Totet
Journal:  J Clin Microbiol       Date:  2013-07-31       Impact factor: 5.948

Review 10.  PCR-based diagnosis of human fungal infections.

Authors:  Prasanna D Khot; David N Fredricks
Journal:  Expert Rev Anti Infect Ther       Date:  2009-12       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.